Clinical trial
A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Painful HIV-Associated Distal Symmetrical Polyneuropathy
NCT00064623 is registered in ClinicalTrials.gov with NeurogesX as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Painful HIV-Associated Distal Symmetrical Polyneuropathy
- Lead sponsor
- NeurogesX
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2003
- Completion date
- November 30, 2005
- Enrollment
- 300
- Sites
- 35
Conditions
As the registry lists them; a condition with its own page is linked.